May 17, 2012 - 1:26 pm
Hi all! I wanted to share this press release from this morning. Good news I hope!
41 US Clinical Trial Sites Now In Operation
BETHESDA, MD, May 17, 2012 -- Northwest Biotherapeutics (OTC.BB: NWBO) (NW Bio) announced today that it now has 41 clinical trial sites open and recruiting across the United States in its ongoing clinical trial of DCVax ®-L immune therapy for Glioblastoma multiforme (GBM), the most lethal form of brain cancer. This is ahead of the Company’s previous projection of 40 sites by the end of Q2, 2012.
The Company plans to continue adding clinical trial sites in the US and Europe, and expects to have at least 60 sites open and enrolling by the end of Q3, 2012.
For further information about the Company and its programs, please visit the Company’s website at www.nwbio.com.
About Northwest Biotherapeutics